Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that controls https://keithxdzq529222.blogrelation.com/45495035/semaglutide-a-potential-solution-for-obesity